Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARLYmyo-CRPⅠ: ARNI in Post-AMI
NCT04342351Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- May 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sacubitril + valsartan in myocardial infarction (MI) (2 arms), sponsored by Renji Hospital. Primary endpoints: Peak oxygen consumption per kilogram at 3 months, Peak Oxygen Pulse at 3 months and 1 more. Status: unknown.
02
Drugs
sacubitril + valsartan
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT04342351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04342351.